Browsing: Podcasts

The Oncology Journal Club Episode 52: Do Steroids Matter? + No-Go, Slow-Go, Go-Go + Essential Medicines Access Welcome to this week’s episode of The OJC. Join Eva Segelov, Craig Underhill and Hans Prenen as they chat through the latest papers. This week they discuss No-Go, Slow-Go, Go-Go, Essential Medicines Access. And they ask Do Steroids Matter? Quick bites are diverse as ever covering Doctors’ strikes in Nigeria, Sex and Toxicity in Colorectal Cancer and much more. You’ll also find out why you should never feel sorry for Hans again despite the fact that he wants a colonoscopy for his birthday!…

The Oncology Journal Club Episode 51: Prostate Cancer Screening, ASCO Guidelines and Infigratinib Welcome to this week’s episode of The OJC. Join Eva Segelov, Craig Underhill and Hans Prenen as they review an eclectic mix of papers covering prostate cancer screening, ASCO guidelines for immunotherapy for locally advanced esophageal carcinoma, infigratinib in advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements, Quick Bites, Zoom Fatigue and much more. We hope you enjoy the Amazing Article of the Week, the Practice Tip of the Week and have a few laughs too. Drop us a line on Twitter with any comments @oncologynewsaus…

The Oncology Journal Club Episode 50: ESMO 2021 Early Bird Practice Changers 2 Welcome to our final ESMO 2021 Special. As with last week’s episode, we’re focussed on early bird practice changing data. We cover GU, Breast and GI cancers, workforce issues and much more. So join us to digest the key ESMO updates with Eva Segelov, Craig Underhill and Hans Prenen. We hope you have a few laughs too. We hope you enjoy listening… drop us a line on Twitter with any comments @oncologynewsaus This Week’s Papers: Fizazi, K. et al. A phase III trial with a 2×2 factorial…

A large prospective study of COVID-19 outcomes in people with a history of cancer has found that hospital mortality rates do not appear to have reduced over time, unlike those for people with no history of cancer. The findings from the Clinical Characterisation Protocol (CCP) CANCER-UK study – which is led by Liverpool researchers in collaboration with colleagues in Edinburgh – are based on anonymised data from more than 195,000 people hospitalised in the UK, including more than 20,000 with a history of cancer, defined as either being on active treatment for cancer or having had a past diagnosis of…

The Oncology Journal Club Episode 49: ESMO 2021 Early Bird Practice Changers Welcome to our first ESMO 2021 Special Episode. Today’s episode is focused on early bird practice changing data. We cover KEYNOTE-716, both the breast and lung DESTINY studies, ZENITH20, TULIP, KEYNOTE-826, COVID and much more. So join us to digest the key ESMO updates with Eva Segelov, Craig Underhill and Hans Prenen. We hope you have a few laughs too. We hope you enjoy listening… drop us a line on Twitter with any comments @oncologynewsaus This Week’s Papers: 1. Luke JJ et al. Pembrolizumab versus placebo after complete resection…

The Oncology Podcast, brought to you by oncologynews.com.au, is proud to present the latest episode in our ‘The OJC Meets…’ series. Today’s special episode is a tweetutorial dedicated to oncology ontology and Twitter hashtags. Eva Segelov and Craig Underhill meet Matthew Katz and Andrew Parsonson. How did this episode come about? Andrew tweeted asking for advice on cancer tag ontology – Matthew Katz recently published a paper on organizing online health content. With the power of Twitter and the OJC we’ve brought them together to chat. So if you have a question for us please don’t hesitate to get in touch.…

The Oncology Journal Club Episode 48: Procrastination and P Values Welcome to another entertaining and informative episode. We’re all about the P’s this week! Procrastination, P Values and yes, peeing. Eva Segelov talks us through avoiding common P Value pitfalls and understanding statistical significance. Craig Underhill looks at Bone Resorption Inhibitors in Metastatic Castration-Resistant Prostate Cancer. And Hans Prenen talks us through a fascinating study exploring how EGFR activation limits the response of liver cancer to Lenvatinib. Quick bites are as diverse as ever and you’ll learn why procrastination is good for creativity in the Amazing Article of the week……

The Oncology Journal Club Episode 47: Fake Cancer News and Conflicts of Interest This week Eva Segelov talks us through a practice changing paper on the duration of adjuvant aromatase-inhibitor therapy in postmenopausal breast cancer. Craig Underhill looks at the KEYNOTE-598 study on metastatic non-small-cell lung cancer aaaaand Hans Prenen is back! He tackles the therapeutic implications of germline testing in advanced cancers. Quick bites are as diverse as ever covering the NeoSCOPE trial, text messaging, cancer misinformation and fake news, conflicts of interest, liquid biopsies and much more. We hope you enjoy listening… drop us a line on Twitter with…

The Oncology Podcast, brought to you by Oncology News Australia, is proud to present Episode 46 in our series The Oncology Journal Club. This week Eva Segelov talks us through an early detection test using an independent validation set. Craig Underhill looks at systematic barriers to participation in cancer treatment trials by Aboriginal and Torres Strait Islander cancer patients. Hans Prenen is still MIA this episode but he’ll be back soon. In the meantime, Eva also has a great selection of Quick Bites including a paper on COVID and burnout – which is a great moment to mention that in…

The Oncology Podcast, brought to you by Oncology News Australia, is proud to present Episode 45 in our series The Oncology Journal Club. In today’s episode Eva Segelov and Craig Underhill cover a great selection of papers. Craig’s main paper discussion is on the St. Gallen International Consensus Guidelines for treatment of early breast cancer. This is a must listen for anyone treating breast cancer and for trainees also. Eva’s main paper today is on the challenges of cancer care for the LGBTQ+ community – she’s joined by Dr Liz Ahern to discuss this important issue. About The Oncology Journal…

1 2 3 7